Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Cognitive impairment is not equal in patients with epileptic and psychogenic nonepileptic seizures.

Drane DL, Williamson DJ, Stroup ES, Holmes MD, Jung M, Koerner E, Chaytor N, Wilensky AJ, Miller JW.

Epilepsia. 2006 Nov;47(11):1879-86.

2.

Effect of vagus nerve stimulation on adults with pharmacoresistant generalized epilepsy syndromes.

Holmes MD, Silbergeld DL, Drouhard D, Wilensky AJ, Ojemann LM.

Seizure. 2004 Jul;13(5):340-5.

3.

Identifying potential surgical candidates in patients with evidence of bitemporal epilepsy.

Holmes MD, Miles AN, Dodrill CB, Ojemann GA, Wilensky AJ.

Epilepsia. 2003 Aug;44(8):1075-9.

4.

Evidence That Emotional Maladjustment Is Worse in Men Than in Women with Psychogenic Nonepileptic Seizures.

Holmes MD, Dodrill CB, Bachtler S, Wilensky AJ, Ojemann LM, Miller JW.

Epilepsy Behav. 2001 Dec;2(6):568-573.

PMID:
12609391
5.

Singing seizures.

Doherty MJ, Wilensky AJ, Holmes MD, Lewis DH, Rae J, Cohn GH.

Neurology. 2002 Nov 12;59(9):1435-8.

PMID:
12427900
6.

Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy.

Vossler DG, Wilensky AJ, Cawthon DF, Kraemer DL, Ojemann LM, Caylor LM, Morgan JD.

Epilepsia. 2002 Feb;43(2):154-9.

7.

Interictal, unifocal spikes in refractory extratemporal epilepsy predict ictal origin and postsurgical outcome.

Holmes MD, Kutsy RL, Ojemann GA, Wilensky AJ, Ojemann LM.

Clin Neurophysiol. 2000 Oct;111(10):1802-8.

PMID:
11018495
8.

Outcome after surgery in patients with refractory temporal lobe epilepsy and normal MRI.

Holmes MD, Born DE, Kutsy RL, Wilensky AJ, Ojemann GA, Ojemann LM.

Seizure. 2000 Sep;9(6):407-11.

9.

Valproate therapy for prevention of posttraumatic seizures: a randomized trial.

Temkin NR, Dikmen SS, Anderson GD, Wilensky AJ, Holmes MD, Cohen W, Newell DW, Nelson P, Awan A, Winn HR.

J Neurosurg. 1999 Oct;91(4):593-600.

PMID:
10507380
10.

Differences in the urinary excretion of 6-beta-hydroxycortisol/cortisol between Asian and Caucasian women.

Lin Y, Anderson GD, Kantor E, Ojemann LM, Wilensky AJ.

J Clin Pharmacol. 1999 Jun;39(6):578-82.

PMID:
10354961
11.

Predicting outcome following reoperation for medically intractable epilepsy.

Holmes MD, Wilensky AJ, Ojemann LM, Ojemann GA.

Seizure. 1999 Apr;8(2):103-6.

12.
13.

High-resolution inter-ictal SPET and phased-array MRI in partial epilepsy: an imaging comparison with video/EEG and outcome correlation.

Lewis DH, Ory P, Holmes MD, Wilensky AJ, Cohen WA, Schneider J, Ojemann LM, Ojemann GA.

Nucl Med Commun. 1998 Mar;19(3):199-206.

PMID:
9625494
14.

Outcome following surgery in patients with bitemporal interictal epileptiform patterns.

Holmes MD, Dodrill CB, Ojemann GA, Wilensky AJ, Ojemann LM.

Neurology. 1997 Apr;48(4):1037-40.

PMID:
9109896
15.

Revised Winter-Tozer equation for normalized phenytoin concentrations in trauma and elderly patients with hypoalbuminemia.

Anderson GD, Pak C, Doane KW, Griffy KG, Temkin NR, Wilensky AJ, Winn HR.

Ann Pharmacother. 1997 Mar;31(3):279-84.

PMID:
9066931
16.

Unilateral focal preponderance of interictal epileptiform discharges as a predictor of seizure origin.

Holmes MD, Dodrill CB, Wilensky AJ, Ojemann LM, Ojemann GA.

Arch Neurol. 1996 Mar;53(3):228-32.

PMID:
8651875
17.

Decreased plasma protein binding of valproate in patients with acute head trauma.

Anderson GD, Gidal BE, Hendryx RJ, Awan AB, Temkin NR, Wilensky AJ, Winn HR.

Br J Clin Pharmacol. 1994 Jun;37(6):559-62.

18.

Lorazepam-valproate interaction: studies in normal subjects and isolated perfused rat liver.

Anderson GD, Gidal BE, Kantor ED, Wilensky AJ.

Epilepsia. 1994 Jan-Feb;35(1):221-5.

PMID:
8112251
19.

Measurement of in vivo microsomal epoxide hydrolase activity in white subjects.

Kroetz DL, Kerr BM, McFarland LV, Loiseau P, Wilensky AJ, Levy RH.

Clin Pharmacol Ther. 1993 Mar;53(3):306-15.

PMID:
8453849
20.

Protocol design.

Wilensky AJ.

Epilepsy Res Suppl. 1993;10:107-13. Review. No abstract available.

PMID:
8251086
21.

Long-term treatment with gabapentin for partial epilepsy.

Ojemann LM, Wilensky AJ, Temkin NR, Chmelir T, Ricker BA, Wallace J.

Epilepsy Res. 1992 Nov;13(2):159-65.

PMID:
1464301
22.

Effect of valproate dose on formation of hepatotoxic metabolites.

Anderson GD, Acheampong AA, Wilensky AJ, Levy RH.

Epilepsia. 1992 Jul-Aug;33(4):736-42.

PMID:
1628592
23.

Neuropsychological abilities before and after 5 years of stable antiepileptic drug therapy.

Dodrill CB, Wilensky AJ.

Epilepsia. 1992 Mar-Apr;33(2):327-34.

PMID:
1547762
24.

Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acid.

Levy RH, Rettenmeier AW, Anderson GD, Wilensky AJ, Friel PN, Baillie TA, Acheampong A, Tor J, Guyot M, Loiseau P.

Clin Pharmacol Ther. 1990 Sep;48(3):225-35.

PMID:
2119269
25.

A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures.

Temkin NR, Dikmen SS, Wilensky AJ, Keihm J, Chabal S, Winn HR.

N Engl J Med. 1990 Aug 23;323(8):497-502.

26.

Intellectual impairment as an outcome of status epilepticus.

Dodrill CB, Wilensky AJ.

Neurology. 1990 May;40(5 Suppl 2):23-7. Review.

PMID:
2185437
27.

Beta-oxidation of valproic acid. I. Effects of fasting and glucose in humans.

Koch KM, Wilensky AJ, Levy RH.

Epilepsia. 1989 Nov-Dec;30(6):782-9.

PMID:
2512112
28.

Inhibition of human liver microsomal epoxide hydrolase by valproate and valpromide: in vitro/in vivo correlation.

Kerr BM, Rettie AE, Eddy AC, Loiseau P, Guyot M, Wilensky AJ, Levy RH.

Clin Pharmacol Ther. 1989 Jul;46(1):82-93. Erratum in: Clin Pharmacol Ther 1989 Sep;46(3):343.

PMID:
2501059
29.

Fundamentals of carbamazepine use in neuropsychiatry.

Neppe VM, Tucker GJ, Wilensky AJ.

J Clin Psychiatry. 1988 Apr;49 Suppl:4-6. Review.

PMID:
3280561
30.

Serum prolactins in the diagnosis of epilepsy: sensitivity, specificity, and predictive value.

Yerby MS, van Belle G, Friel PN, Wilensky AJ.

Neurology. 1987 Jul;37(7):1224-6.

PMID:
3601088
31.

The role of psychosocial and financial factors in medication noncompliance in epilepsy.

Dodrill CB, Batzel LW, Wilensky AJ, Yerby MS.

Int J Psychiatry Med. 1987;17(2):143-54.

PMID:
3610480
32.

Comparative pharmacokinetics of zonisamide (CI-912) in epileptic patients on carbamazepine or phenytoin monotherapy.

Ojemann LM, Shastri RA, Wilensky AJ, Friel PN, Levy RH, McLean JR, Buchanan RA.

Ther Drug Monit. 1986;8(3):293-6.

PMID:
3750373
33.

Pharmacokinetics of W-554 (ADD 03055) in epileptic patients.

Wilensky AJ, Friel PN, Ojemann LM, Kupferberg HJ, Levy RH.

Epilepsia. 1985 Nov-Dec;26(6):602-6.

PMID:
4076064
34.

Efficacy of nafimidone in the treatment of intractable partial seizures: report of a two-center pilot study.

Treiman DM, Wilensky AJ, Ben-Menachem E, Ojemann L, Yerby M, Barber KO, McCormick KB, Cereghino JJ, White BG, Swisher K.

Epilepsia. 1985 Nov-Dec;26(6):607-11.

PMID:
3935425
35.

Zonisamide in epilepsy: a pilot study.

Wilensky AJ, Friel PN, Ojemann LM, Dodrill CB, McCormick KB, Levy RH.

Epilepsia. 1985 May-Jun;26(3):212-20.

PMID:
4006880
36.

Filtration for free drug level monitoring: carbamazepine and valproic acid.

Levy RH, Friel PN, Johno I, Linthicum LM, Colin L, Koch K, Raisys VA, Wilensky AJ, Temkin NR.

Ther Drug Monit. 1984;6(1):67-76.

PMID:
6424279
37.

Cinromide in epilepsy: a pilot study.

Wilensky AJ, Ojemann LM, Friel PN, Almes MJ, Levy RH, Dodrill CB.

Epilepsia. 1983 Aug;24(4):401-9.

PMID:
6409598
38.

Validity of the Minnesota Multiphasic Personality Inventory (MMPI) to psychopathology in patients with epilepsy.

Dikmen S, Hermann BP, Wilensky AJ, Rainwater G.

J Nerv Ment Dis. 1983 Feb;171(2):114-22.

PMID:
6822818
39.

Increased psychopathology associated with multiple seizure types: fact or artifact?

Hermann BP, Dikmen S, Wilensky AJ.

Epilepsia. 1982 Dec;23(6):587-96.

PMID:
7173126
40.

The influence of free fatty acids on valproic acid plasma protein binding during fasting in normal humans.

Bowdle TA, Patel IH, Levy RH, Wilensky AJ.

Eur J Clin Pharmacol. 1982 Oct;23(4):343-7.

PMID:
6816619
41.

Ethosuximide kinetics: possible interaction with valproic acid.

Bauer LA, Harris C, Wilensky AJ, Raisys VA, Levy RH.

Clin Pharmacol Ther. 1982 Jun;31(6):741-5.

PMID:
6804151
42.

Kinetics of phenobarbital in normal subjects and epileptic patients.

Wilensky AJ, Friel PN, Levy RH, Comfort CP, Kaluzny SP.

Eur J Clin Pharmacol. 1982;23(1):87-92.

PMID:
7128675
43.

Clorazepate and phenobarbital as antiepileptic drugs: a double-blind study.

Wilensky AJ, Ojemann LM, Temkin NR, Troupin AS, Dodrill CB.

Neurology. 1981 Oct;31(10):1271-6.

PMID:
6125918
44.

Differential kinetics of cinromide and two of its metabolites in epileptic patients.

Wilensky AJ, Lane EA, Levy RH, Ojemann LM, Friel PN.

Eur J Clin Pharmacol. 1981;21(2):149-53.

PMID:
7341282
45.

High-performance liquid chromatographic and gas-liquid chromatographic determination of diazepam and nordiazepam in plasma.

Raisys VA, Friel PN, Graaff PR, Opheim KE, Wilensky AJ.

J Chromatogr. 1980 Oct 10;183(4):441-8.

PMID:
6776133
46.

Valproic acid dosage and plasma protein binding and clearance.

Bowdle AT, Patel IH, Levy RH, Wilensky AJ.

Clin Pharmacol Ther. 1980 Oct;28(4):486-92.

PMID:
6773716
47.

Clinical pharmacology of mephenytoin and ethotoin.

Troupin AS, Friel P, Lovely MP, Wilensky AJ.

Ann Neurol. 1979 Nov;6(5):410-4.

PMID:
42344
48.

Pharmacokinetics of primidone in mice after acute and chronic administration.

Leal KW, Friel PN, Rapport RL, Wilensky AJ.

Drug Metab Dispos. 1979 Sep-Oct;7(5):345. No abstract available.

PMID:
40779
49.

Hepatic failure from valproic acid.

Bowdle TA, Patel IH, Wilensky AJ, Comfort C.

N Engl J Med. 1979 Aug 23;301(8):435-6. No abstract available.

PMID:
379646
50.

Single-dose pharmacokinetics and anticonvulsant efficacy of primidone in mice.

Leal KW, Rapport RL, Wilensky AJ, Friel PN.

Ann Neurol. 1979 May;5(5):470-4.

PMID:
464548

Supplemental Content

Loading ...
Support Center